This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (51) Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Helmers, S. L. Articles by Madsen, J. R. Search for Related Content PubMed PubMed Citation Articles by Helmers, S. L. Articles by Madsen, J. R. Social Bookmarking                         What's this?

Vagus Nerve Stimulation Therapy in Pediatric Patients With Refractory Epilepsy: Retrospective Study

Department of Neurology, Division of Epilepsy and Clinical Neurophysiology, Children's Hospital, Ankara, Turkey, sandra_helmers{at}Emory.org.

James W. Wheless, MD

Texas Comprehensive Epilepsy Program, University of Texas-Houston, TX

Michael Frost, MD

Minnesota Epilepsy Group of United Children's Hospital, St. Paul, MN

John Gates, MD

Minnesota Epilepsy Group of United Children's Hospital, St. Paul, MN

Paul Levisohn, MD

Department of Pediatrics and Neurology, University of Colorado Health Sciences Center, and Children's Hospital, Denver, CO

Carmelo Tardo, MD

Louisiana State University Comprehensive Epilepsy Center, New Orleans, LA

Joan A. Conry, MD

Department of Neurology, Children's National Medical Center, Washington, DC

Dilek Yalnizoglu, MD

Hacettepe University Children's Hospital, Ankara, Turkey

Joseph R. Madsen, MD

Department of Neurosurgery, Harvard Medical School, Boston, MA

This six-center, retrospective study evaluated the effectiveness, tolerability, and safety of vagus nerve stimulation in children. Data were available for 125 patients at baseline, 95 patients at 3 months, 56 patients at 6 months, and 12 patients at 12 months. The typical patient, aged 12 years, had onset of seizures at age 2 years and had tried nine anticonvulsants before implantation. Collected data included preimplant history, seizures, implant, device settings, quality of life, and adverse events. Average seizure reduction was 36.1% at 3 months and 44.7% at 6 months. Common adverse events included voice alteration and coughing during stimulation. Rare adverse events, unique to this age group, included increased drooling and increased hyperactivity. Quality of life improved in alertness, verbal communication, school performance, clustering of seizures, and postictal periods. We concluded that vagus nerve stimulation is an effective treatment for medically refractory epilepsy in children. (J Child Neurol 2001;16:843—848).

Journal of Child Neurology, Vol. 16, No. 11, 843-848 (2001)
DOI: 10.1177/08830738010160111101


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				E. M. S. Sherman, M. B. Connolly, D. J. Slick, K. L. Eyrl, P. Steinbok, and K. Farrell Quality of Life and Seizure Outcome After Vagus Nerve Stimulation in Children With Intractable Epilepsy J Child Neurol, September 1, 2008; 23(9): 991 - 998. [Abstract] [PDF]